Good news that the US is purchasing another 100 million doses each from Pfizer and Moderna. We will certainly have lots of vaccine on hand by the summertime. In fact, I imagine that we may have a surplus and will eventually sell it to other countries as demand dries up in the US by the fall. J&J and AstraZenaca vaccines will also be coming online, so in a few months things are going to look better and it will become very easy to go to your local pharmacy and get a vaccine.
As we get through the first tier of recipients (mostly healthcare workers and people 65 and older), I am wondering how the next tier is going to go. It seems that there is going to be no way to really monitor who is in the next level priority - essential workers and/or people with at-risk conditions. That's a wildly broad category; almost everyone can pigeon-hole themselves into one of those categories.
So would it be better to either a) just open it up to everyone; or b) open it up by age brackets (55 and older; then 45 and older; etc) that you can at least control?